PA
ANTH

Perceptive Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Perceptive Advisors’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-182,453
Closed -$4.6M – 235
2016
Q3 		$4.6M Sell
182,453
-4,067
-2% -$103K 0.3% 71
2016
Q2 		$4.61M Hold
186,520
– – 0.32% 61
2016
Q1 		$5.4M Buy
186,520
+62,500
+50% +$1.7M 0.47% 53
2015
Q4 		$4.6M Hold
124,020
– – 0.34% 54
2015
Q3 		$5.21M Sell
124,020
-26,250
-17% -$1.83M 0.42% 58
2015
Q2 		$10.4M Sell
150,270
-50,125
-25% -$2.32M 0.62% 40
2015
Q1 		$7.17M Buy
200,395
+137,500
+219% +$4.07M 0.56% 40
2014
Q4 		$795K Buy
62,895
+3,088
+5% +$44.9K 0.07% 106
2014
Q3 		$919K Hold
59,807
– – 0.09% 86
2014
Q2 		$1.62M Hold
59,807
– – 0.16% 71
2014
Q1 		$1.6M Buy
59,807
+5,875
+11% +$149K 0.17% 79
2013
Q4 		$1.32M Hold
53,932
– – 0.16% 62
2013
Q3 		$1.73M Hold
53,932
– – 0.14% 63
2013
Q2 		$1.6M Buy
+53,932
New +$2.01M 0.16% 51

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Perceptive Advisors's ANTH Position: Q4 2016 in Review

Perceptive Advisors sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2016, closing a stake of 182,453 shares — an estimated $4.6M sold.

Perceptive Advisors first reported a position in ANTH in Q2 2013 and held it in 14 quarters. The position peaked at $10.4M in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q4 2016.

  • Perceptive Advisors reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Perceptive Advisors sold 182,453 Anthera Pharmaceuticals, Inc. shares in Q4 2016, an estimated $4.6M.
  • Perceptive Advisors first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • Perceptive Advisors's Anthera Pharmaceuticals, Inc. position peaked at $10.4M in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2016.

Based on Perceptive Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.